Aurinia Pharmaceuticals I... (AUPH)
NASDAQ: AUPH
· Real-Time Price · USD
12.21
0.12 (0.99%)
At close: Aug 15, 2025, 12:01 PM
Aurinia Pharmaceuticals Revenue
Aurinia Pharmaceuticals reported an annual revenue of $235.13M, reflecting a 33.97% growth. For the quarter ending June 30, 2025, Aurinia Pharmaceuticals generated $70.01M in revenue.
Revenue (ttm)
235.13M
Revenue Growth
33.97%
Price / Sales Ratio
5.46
Revenue / Employee
1.81M
Employees
130
Market Cap
1.61B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|